Previous Conference

Total 250* sessions to learn everything on the Asian bio/pharma industry! (*expected)

From the latest topics addressed by industry leaders to presentations by academics and start-ups.

All FREE with the Member Registration

Keynote Session
Growth Strategy and Future Vision

May 11 [Wed]
Pharmaceutical Companies'
R&D Strategies

May 11 [Wed]
CRISPR and Cryo-EM in Drug Discovery

May 13 [Fri]

Asian Biotech and Healthcare Trends
May 13 [Fri]
Genome Medicine
May 11 [Wed]
Personalized Medicine and Regulatory Science
May 12 [Thu]
Biopharmaceuticals Outsourcing
May 13 [Fri]
  • ※Entry is free of charge with VIP privilege or Member Registration

    FREE with Member Registration
    Click here for Details

    Keynote Session

    May 11[Wed] 10:00-12:00
    Bilingual (English/Japanese)

    Healthcare Industry - Growth Strategy and Future Vision -

    Chairman: Ken-ichi Arai
    Professor Emeritus,
    The University of Tokyo/
    Director, Chairman,
    SBI Biotech Co., Ltd.
    AMED Challenges for Overcoming Balkanization
    Makoto Suematsu
    Japan Agency for Medical Research and Development (AMED)
    Integration of Information Revolution and Biomedical Revolution: Predictive and Preventive Medicine Based on IoT and AI
    Kazuhiro Sakurada
    Senior Researcher,
    Sony Computer Science Laboratories, Inc. /
    Senior Researcher, Medical Business Unit,
    Sony Corp. /
    Deputy Director, Medical Sciences Innovation Hub Program,
    Life Sciences Potential in Lithuania
    Marius Skarupskas
    Vice Minister,
    Ministry of Economy of Republic of Lithuania

    * Please note that the speaker
    has changed as above.
    (As of Monday, April 25, 2016)

    Go to TOP

  • FREE with Member Registration
    Click here for Details

    Keynote Session

    May 11[Wed] 13:00-14:30 Bilingual (English/Japanese)

    Pharmaceutical Companies: R&D Strategies in the New Era

    Chairman: Toichi Takenaka
    Chairman, Japan Health Sciences Foundation/
    Program Director, Project for Drug Discovery and Development,
    Japan Agency for Medical Research and Development(AMED)
    Next Generation Antibody Medicines

    Hisafumi Okabe
    Senior Vice President, General Manager,
    Research Div.,
    Chugai Pharmaceutical Co., Ltd.

    Open Innovation in Drug Discovery
    Masaki Yamada
    Associate Director,
    Sohyaku Strategy & Planning Dept.,
    Sohyaku. Innovative Research Div.,
    Mitsubishi Tanabe Pharma Corp.
  • FREE with Member Registration
    Click here for Details

    May 13[Fri] 15:00-16:30 Bilingual (English/Japanese)

    Structural Biology Opening up the World of Drug Discovery - CRISPR and Cryo-EM -

    Chairman: Tatsuhiko Kodama
    Dept. of Systems Biology and Medicine,
    Research Center for Advanced Science and Technology,
    The University of Tokyo
    Rise of Cryo-EM: Applications to Biology and Medicine
    Sriram Subramaniam
    Senior Investigator,
    National Cancer Institute, NIH
    Structure-based Design of Genome Editing Tool of CRISPR-Cas9 and Its Application to Cellular Therapy
    Osamu Nureki
    Graduate School of Science,
    The University of Tokyo/
    Scientific founder and Board member,
    EdiGENE Corp.
  • FREE with Member Registration
    Click here for Details

    May 13[Fri] 12:30-14:00 Bilingual (English/Japanese)

    Asia's Latest Biotechnology and Healthcare Industry Trends

    Light Up the Way of Biotech from Startups to Market
    Richard Shau
    VP & General Director,
    Biomedical Technology and Device Research Lab.,
    (Industrial Technology Research Institute)
    Biotech Industry in India
    Chandra Prakash Goyal
    Joint Secretary,
    Dept. of Biotechnology,
    Ministry of Science and Technology, Government of India
  • FREE with Member Registration
    Click here for Details
    PHAR-1 May 11[Wed] 15:30-17:00 Bilingual (English/Japanese)

    Japan's Genome Medicine Strategy

    Chairman: Tsutomu Nobori
    Professor Emeritus,
    Mie University

    Current Trends and Challenges of Pharmaceutical Development

    Yoshihide Esaki
    Healthcare Service Industry Div.,
    Ministry of Economy,
    Trade and Industry
  • FREE with Member Registration
    Click here for Details

    May 12[Thu] 10:00-11:30
    Bilingual (English/Japanese)

    Progress of Personalized Medical Care and Regulatory Science

    Chairman: Shuichi Hayashi
    Vice President,
    Roche Diagnostics K.K.
    Regulatory Perspective and Consideration on the Promotion of Personalized Medicine
    Mayumi Shikano
    Associate Director,
    Center for Product Evaluation,
    Pharmaceuticals and Medical Devices Agency(PMDA)
    BRACAnalysis CDx and Olaparib Co-approvals
    Yu-Zhen Liu
    Diagnostic Expert,
    Personalised Healthcare and Biomarkers,
    AstraZeneca Ltd.
    BRCA Test as a Companion Diagnostics in Japan
    Seiichi Yano
    Translational Science Dept.,
    Science Affairs Div.,
    Research & Development,
    AstraZeneca K.K.
    FREE with Member Registration
    Click here for Details
    PHAR-5 May 13[Fri] 10:00-11:30 Bilingual (English/Japanese)

    Approaches to Biopharmaceuticals: Outsourcing

    Chairman: Kenya Shitara
    Executive Officer,
    Legal and Intellectual Property Dept.,
    Kyowa Hakko Kirin Co., Ltd.
    JSR Approach to Biomedicine
    Hozumi Satou
    Representative Director and Executive Vice President,
    JSR Corp.
    Better CMO Service by Samsung BioLogics
    TH Kim
    President & CEO,
    Samsung BioLogics
  • Other sessions in Japanese Only

    >>Click here to see details (available only in Japanese)

    -(Honorifics omitted) Please note that the speakers and programs are subject to change.
    The photographic and video recording rights are reserved to the Show Management.

    About Life Science World 2016